| 17-Phenyl-trinor-prostaglandin E2 is a synthetic analog of PGE2 and an agonist at the EP1 and EP3 receptor. Prostaglandin E2(PGE2) regulates neuroinflammatory responses and is upregulated in brain injury by cyclooxygenase 2 (COX-2) and membrane-bound PGE synthase. 17-Phenyl-trinor-prostaglandin E2 can be used to investigate inflammatory signaling pathways. Synonyms: 9-oxo-11alpha,15S-dihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-oic acid, (5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-5-oxocyclopentyl]-5-heptenoic Acid, [1R-[1alpha(Z),2beta(1E,3S*),3alpha]]-7-[3-Hydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)-5-oxocyclopentyl]-5-heptenoic Acid, (5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-5-oxocyclopentyl]-5-heptenoic Acid, 17-Phenyl-18,19,20-trinor-PGE2, 17-Phenyl-18,19,20-trinorprostaglandin E2, 17-Phenyl-omega-trinor-PGE2, 17-Phenyltrinor-PGE2, CL 116147 CAS No: 38315-43-4 Molecular Formula: C23H30O5 Molecular Weight: 386.48 Purity: 98% Appearance: Crystalline solid Solubility (100mg/ml): Ethanol, DMF and DMSO Infared Radiation: Conforms to structure Method for Determining Identity: Mass Spectometry Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. |
